Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Nockchain Nockchain +26.75%
#4 Fabric Protocol Fabric Protocol +22.84%
#5 Bedrock Bedrock +13.53%
#6 Cysic Cysic +13.33%
#7 Perle Perle +10.02%
#8 Arowana Arowana +8.26%
#9 Theta Network Theta Network +7.24%
#10 Velvet Velvet +6.70%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
BerGenBio ASA BerGenBio ASA

BerGenBio ASA

BGBIO
Rank in Stocks #37880
BerGenBio ASA is a biopharmaceutical firm in the clinical development stage,... BerGenBio ASA is a biopharmaceutical firm in the clinical development stage, focused on developing therapies for drug-resistant, immune-evasive, and metastatic cancers, in addition to respiratory conditions. Its leading compound, Bemcentinib, is a bio-available small molecule AXL inhibitor currently in Phase II clinical trials for major cancer indications and COVID-19. The Phase II trial program specifically addresses non-small cell lung cancer, acute myeloid leukemia, myelodysplastic syndrome, and COVID-19. Moreover, the company is progressing tilvestamab, an anti-AXL antibody, through Phase Ib clinical trials. BerGenBio ASA also maintains a collaboration agreement with Merck & Co. for its clinical studies. The company was founded in 2007 and operates from its base in Bergen, Norway.
Share Price
$0.051239
Last synced: 2025-11-24
Market Cap
$1.38M
Change (1 day)
-4.48%
Change (1 year)
-54.57%
Country
NO
Trade BerGenBio ASA (BGBIO)

Category

Healthcare
P/B ratio for BerGenBio ASA (BGBIO)
P/B ratio as of 2026 TTM: 0
According to BerGenBio ASA latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for BerGenBio ASA from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE